Skip to main content

Immune Tolerance Network

A clinical research consortium sponsored by NIAID and JDRF

A clinical trial for relapsing-remitting multiple sclerosis

Home
About MS
The Study Drug
Who is Eligible?
About Participating
Study Locations

About Participating

Not Enrolling Participants

The ACCLAIM study is active, but is not enrolling participants at this time.

ACCLAIM is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded), with support from the Juvenile Diabetes Research Foundation.

© 2011 Immune Tolerance Network

Terms & Conditions
Privacy
Accessibility